Carroll J C, Reid A J, Woodward C A, Permaul-Woods J A, Domb S, Ryan G, Arbitman S, Fallis B, Kilthei J
Mount Sinai Hospital Family Medicine Centre, Toronto, Ont.
CMAJ. 1997 Mar 15;156(6):775-84.
To determine the practices, knowledge and opinions of health care providers regarding a prenatal genetic screening program in Ontario.
Cross-sectional self-reported survey.
Ontario.
Random sample of 2000 family physicians, all 565 obstetricians and all 62 registered midwives in the province. Among subjects who were eligible (those providing antenatal care or attending births) the response rates were 91% (778/851), 76% (273/359) and 78% (46/59) respectively.
Which patients were offered maternal serum screening (MSS), how results were being communicated, knowledge of the test's sensitivity, likes and dislikes about MSS and recommendations regarding the program.
Most (97%) of respondents stated that they were offering MSS to the pregnant women in their practices; 88% were offering it routinely to all pregnant women (87% of the family physicians, 90% of the obstetricians and 100% of the midwives). Most (92%) of the respondents stated that they communicate positive results to their patients personally as soon as they are received; 23% did so for negative results. The respondents correctly identified the initial positive rate but underestimated the false-positive rate. About one-third did not respond to these knowledge questions. Of those who gave feedback on the screening program, 50% recommended that it not be changed, 29% suggested that it be changed, and 22% recommended that it be scrapped.
Participation in the Ontario Maternal Serum Screening Program by health care providers has been good, although knowledge about MSS is far from ideal. Many providers have reservations about the program. In light of concerns raised about the high false-positive rate and the anxiety such results generate in pregnant women, there is a need for more education of providers and patients and a better understanding of women's experiences with genetic screening.
确定安大略省医疗服务提供者在产前基因筛查项目方面的做法、知识和观点。
横断面自我报告调查。
安大略省。
该省2000名家庭医生、所有565名产科医生和所有62名注册助产士的随机样本。在符合条件(提供产前护理或接生)的受试者中,回复率分别为91%(778/851)、76%(273/359)和78%(46/59)。
向哪些患者提供母血清筛查(MSS)、结果如何传达、对检测敏感性的了解、对MSS的喜欢和不喜欢以及对该项目的建议。
大多数(97%)受访者表示他们在执业中向孕妇提供MSS;88%的人将其常规提供给所有孕妇(家庭医生中的87%、产科医生中的90%和助产士中的100%)。大多数(92%)受访者表示他们一收到阳性结果就亲自告知患者;23%的人对阴性结果也这样做。受访者正确识别了初始阳性率,但低估了假阳性率。约三分之一的人未回答这些知识问题。在对筛查项目给出反馈的人中,50%建议不做改变,29%建议进行改变,22%建议取消该项目。
医疗服务提供者对安大略省母血清筛查项目的参与度良好,尽管对MSS的了解远不理想。许多提供者对该项目有所保留。鉴于对高假阳性率以及此类结果给孕妇带来的焦虑所引发的担忧,有必要对提供者和患者进行更多教育,并更好地了解女性在基因筛查方面的经历。